Camurus AB (publ) (CAMRF)
OTCMKTS · Delayed Price · Currency is USD
71.00
+3.90 (5.81%)
At close: Jan 9, 2026
Camurus AB Market Cap
Camurus AB has a market cap or net worth of $4.49 billion as of February 12, 2026. Its market cap has increased by 49.58% in one year.
Market Cap
4.49B
Enterprise Value
4.11B
Revenue
249.82M
Ranking
n/a
PE Ratio
54.15
Stock Price
$71.00
Market Cap Chart
Since December 3, 2015, Camurus AB's market cap has increased from 195.65M to 4.49B, an increase of 2,196.08%. That is a compound annual growth rate of 35.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 4.49B | 12.38% |
| Dec 30, 2025 | 4.00B | 32.59% |
| Dec 30, 2024 | 3.01B | 1.60% |
| Dec 29, 2023 | 2.97B | 120.93% |
| Dec 30, 2022 | 1.34B | 46.93% |
| Dec 30, 2021 | 914.06M | -25.91% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 399.44M |
| CytoDyn | 311.51M |
| Silence Therapeutics | 211.61M |
| Vaxart | 145.24M |
| HST Global | 139.70M |
| BioStem Technologies | 105.50M |
| Nuo Therapeutics | 76.77M |
| VitaSpring Biomedical | 51.78M |